Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05467891
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-05
First Post:
2022-06-28
Brief Title:
Ribociclib And Endocrine Treatment of Physicians Choice for Locoregional Recurrent Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor:
Oana Danciu
Organization:
Hoosier Cancer Research Network
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-28
First Submit QC Date:
July 18 2022
Study First Post Date:
2022-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-25
Last Update Post Date:
2024-01-05
Last Update Post Date Type:
ACTUAL